Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Lenvatinib and Anti-PD-1 Antibodies for Unresectable Hepatocellular Carcinoma: A Retrospective Analysis

BACKGROUND: Drug-eluting bead transarterial chemoembolization (DEB-TACE) has good efficacy in the treatment of unresectable hepatocellular carcinoma (uHCC), with a relatively high objective response rate (ORR) compared to conventional transarterial chemoembolization (cTACE). This study aimed to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shao-Jie, Ruan, Dan-Dan, Wu, Qiu-Yan, Tang, Yi, Zhang, Jian-Hui, Cai, Sen-Lin, Zhou, Yan-Feng, Luo, Jie-Wei, Fang, Zhu-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244613/
https://www.ncbi.nlm.nih.gov/pubmed/37292114
http://dx.doi.org/10.2147/JHC.S408819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244613/
https://www.ncbi.nlm.nih.gov/pubmed/37292114
http://dx.doi.org/10.2147/JHC.S408819

Ejemplares similares